-
2
-
-
44149124010
-
Managing antiretroviral therapy: Changing regimens, resistance testing, and the risks from structured treatment interruptions
-
Eron J. Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions. J Infect Dis. 2008;197(Suppl 3):S261-71.
-
(2008)
J Infect Dis
, vol.197
, Issue.SUPPL. 3
-
-
Eron, J.1
-
4
-
-
4544267859
-
Priority strategies for sustainable fight against HIV/AIDS in low-income countries
-
Dionisio D, Esperti F, Messeri D, Vivarelli A. Priority strategies for sustainable fight against HIV/AIDS in low-income countries. Curr HIV Res. 2004;2:377-93.
-
(2004)
Curr HIV Res
, vol.2
, pp. 377-393
-
-
Dionisio, D.1
Esperti, F.2
Messeri, D.3
Vivarelli, A.4
-
6
-
-
0025196791
-
Health implications of war in Uganda and Sudan
-
Dodge C. Health implications of war in Uganda and Sudan. Soc Sci Med. 1990;31:691-8.
-
(1990)
Soc Sci Med
, vol.31
, pp. 691-698
-
-
Dodge, C.1
-
7
-
-
0034660940
-
Conflict and health: The health costs of war: Can they be measured? Lessons from El Salvador
-
Ugalde A, Selva-Sutter E, Castillo C, Paz C, Canas S. Conflict and health: The health costs of war: can they be measured? Lessons from El Salvador. BMJ. 2000;321:169-72.
-
(2000)
BMJ
, vol.321
, pp. 169-172
-
-
Ugalde, A.1
Selva-Sutter, E.2
Castillo, C.3
Paz, C.4
Canas, S.5
-
8
-
-
0028888527
-
Public health impact of Rwandan refugee crisis: What happened in Goma, Zaire, in July, 1994
-
Goma Epidemiology Group
-
Goma Epidemiology Group. Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994. Lancet. 1995;345: 339-44.
-
(1995)
Lancet
, vol.345
, pp. 339-344
-
-
-
9
-
-
77955999371
-
Mortality and health among internally displaced persons in western Kenya following post-election violence, 2008: Novel use of demographic surveillance
-
Feikin D, Adazu K, Obor D, et al. Mortality and health among internally displaced persons in western Kenya following post-election violence, 2008: novel use of demographic surveillance. Bull World Health Organ. 2010;88:601-8.
-
(2010)
Bull World Health Organ
, vol.88
, pp. 601-608
-
-
Feikin, D.1
Adazu, K.2
Obor, D.3
-
11
-
-
78049281900
-
Treatment interruption in a primary care antiretroviral therapy program in South Africa: Cohort analysis of trends and risk factors
-
Kranzer K, Lewis J, Ford N, et al. Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr. 2010;55:e17-23.
-
(2010)
J Acquir Immune Defic Syndr
, vol.55
-
-
Kranzer, K.1
Lewis, J.2
Ford, N.3
-
12
-
-
79956058360
-
The consequences of post-election violence on antiretroviral HIV therapy in Kenya
-
Pyne-Mercier L, John-Stewart G, Richardson B, et al. The consequences of post-election violence on antiretroviral HIV therapy in Kenya. AIDS Care. 2011;23:562-8.
-
(2011)
AIDS Care
, vol.23
, pp. 562-568
-
-
Pyne-Mercier, L.1
John-Stewart, G.2
Richardson, B.3
-
13
-
-
70350004095
-
Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya
-
Vreeman R, Nyandiko W, Sang E, Musick B, Braitstein P, Wiehe S. Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya. Confl Health. 2009;3:5.
-
(2009)
Confl Health
, vol.3
, pp. 5
-
-
Vreeman, R.1
Nyandiko, W.2
Sang, E.3
Musick, B.4
Braitstein, P.5
Wiehe, S.6
-
14
-
-
33846024773
-
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults
-
Pai N, Lawrence J, Reingold A, Tulsky J. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults. Cochrane Database Syst Rev. 2006;3:CD006148.
-
(2006)
Cochrane Database Syst Rev
, vol.3
-
-
Pai, N.1
Lawrence, J.2
Reingold, A.3
Tulsky, J.4
-
16
-
-
80052873078
-
Unstructured treatment interruption of antiretroviral therapy in clinical practice: A systematic review
-
Kranzer K, Ford N. Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Trop Med Int Health. 2011;16:1297-313.
-
(2011)
Trop Med Int Health
, vol.16
, pp. 1297-1313
-
-
Kranzer, K.1
Ford, N.2
-
17
-
-
0036283755
-
Political violence, ethnic conflict, and contemporary wars: Broad implications for health and social well-being
-
Pedersen D. Political violence, ethnic conflict, and contemporary wars: broad implications for health and social well-being. Soc Sci Med. 2002;55:175-90.
-
(2002)
Soc Sci Med
, vol.55
, pp. 175-190
-
-
Pedersen, D.1
-
19
-
-
84883114240
-
-
(Accessed July 07,)
-
A Country Study: El Salvador. (Available at: at http://lcweb2.loc.gov/ frd/cs/svtoc.html. Accessed July 07, 2011).
-
(2011)
A Country Study: El Salvador
-
-
-
20
-
-
77950386666
-
Unplanned antiretroviral treatment interruptions in southern Africa: How should we be managing these?
-
Veenstra N, Whiteside A, Lalloo D, Gibbs A. Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these? Global Health. 2010;6:4.
-
(2010)
Global Health
, vol.6
, pp. 4
-
-
Veenstra, N.1
Whiteside, A.2
Lalloo, D.3
Gibbs, A.4
-
21
-
-
70349984153
-
Providing HIV care in the aftermath of Kenya's post-election violence Medecins Sans Frontieres' lessons learned January - March 2008
-
Reid T, van Engelgem I, Telfer B, Manzi M. Providing HIV care in the aftermath of Kenya's post-election violence Medecins Sans Frontieres' lessons learned January - March 2008. Confl Health. 2008;2:15.
-
(2008)
Confl Health
, vol.2
, pp. 15
-
-
Reid, T.1
Van Engelgem, I.2
Telfer, B.3
Manzi, M.4
-
22
-
-
77649224899
-
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach
-
Geng E, Bangsberg D, Musinguzi N, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53:405-11.
-
(2010)
J Acquir Immune Defic Syndr
, vol.53
, pp. 405-411
-
-
Geng, E.1
Bangsberg, D.2
Musinguzi, N.3
-
23
-
-
13944262121
-
A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection
-
Cardiello P, Hassink E, Ananworanich J, et al. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection. Clin Infect Dis. 2005;40:594-600.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 594-600
-
-
Cardiello, P.1
Hassink, E.2
Ananworanich, J.3
-
24
-
-
23244437092
-
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: The HIV Netherlands Australia Thailand Research Collaboration 001.4 study
-
Ananworanich J, Siangphoe U, Hill A, et al. Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study. J Acquir Immune Defic Syndr. 2005; 39:523-9.
-
(2005)
J Acquir Immune Defic Syndr
, vol.39
, pp. 523-529
-
-
Ananworanich, J.1
Siangphoe, U.2
Hill, A.3
-
25
-
-
33746479812
-
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: Results of the Staccato randomised trial
-
Ananworanich J, Gayet-Ageron A, Le Braz M, et al. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet. 2006;368:459-65.
-
(2006)
Lancet
, vol.368
, pp. 459-465
-
-
Ananworanich, J.1
Gayet-Ageron, A.2
Le Braz, M.3
-
26
-
-
77956405792
-
A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda
-
Reynolds S, Kityo C, Hallahan C, et al. A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda. PLoS One. 2010;5:e10307.
-
(2010)
PLoS One
, vol.5
-
-
Reynolds, S.1
Kityo, C.2
Hallahan, C.3
-
27
-
-
34447304106
-
A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164)
-
Walmsley S, Thorne A, Loutfy M, et al. A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy (Canadian HIV Trials Network Study 164). J Acquir Immune Defic Syndr. 2007;45:418-25.
-
(2007)
J Acquir Immune Defic Syndr
, vol.45
, pp. 418-425
-
-
Walmsley, S.1
Thorne, A.2
Loutfy, M.3
-
28
-
-
77952822874
-
Guidelines for the use of antiretroviral agents in Hiv-1-infected adults and adolescents
-
DHHS. Department of Health and Human Services
-
DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents 2011.
-
(2011)
Panel on Antiretroviral Guidelines for Adults and Adolescents
-
-
-
29
-
-
77954692660
-
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel
-
Thompson M, Aberg J, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304:321-33.
-
(2010)
JAMA
, vol.304
, pp. 321-333
-
-
Thompson, M.1
Aberg, J.2
Cahn, P.3
-
30
-
-
60549096626
-
Dynamics of NRTI resistance mutations during therapy interruption
-
Trignetti M, Sing T, Svicher V, et al. Dynamics of NRTI resistance mutations during therapy interruption. AIDS Res Hum Retroviruses. 2009;25:57-64.
-
(2009)
AIDS Res Hum Retroviruses
, vol.25
, pp. 57-64
-
-
Trignetti, M.1
Sing, T.2
Svicher, V.3
-
31
-
-
58749091289
-
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: A randomized trial involving West African adults
-
Danel C, Moh R, Chaix M, et al. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults. J Infect Dis. 2009;199:66-76.
-
(2009)
J Infect Dis
, vol.199
, pp. 66-76
-
-
Danel, C.1
Moh, R.2
Chaix, M.3
-
32
-
-
0024273119
-
The accuracy of reverse transcriptase from HIV-1
-
Roberts J, Bebenek K, Kunkel T. The accuracy of reverse transcriptase from HIV-1. Science. 1988;242:1171-3.
-
(1988)
Science
, vol.242
, pp. 1171-1173
-
-
Roberts, J.1
Bebenek, K.2
Kunkel, T.3
-
33
-
-
77957658175
-
Quasispecies theory and the behavior of RNA viruses
-
Lauring A, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010;6:e1001005.
-
(2010)
PLoS Pathog
, vol.6
-
-
Lauring, A.1
Andino, R.2
-
34
-
-
79952836893
-
Singlenucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function
-
Shuck-Lee D, Chang H, Sloan E, Hammarskjold M, Rekosh D. Singlenucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function. J Virol. 2011;85:3940-9.
-
(2011)
J Virol
, vol.85
, pp. 3940-3949
-
-
Shuck-Lee, D.1
Chang, H.2
Sloan, E.3
Hammarskjold, M.4
Rekosh, D.5
-
35
-
-
34249341728
-
Adherence-resistance relationships to combination HIV antiretroviral therapy
-
Bangsberg D, Kroetz D, Deeks S. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007; 4:65-72.
-
(2007)
Curr HIV/AIDS Rep
, vol.4
, pp. 65-72
-
-
Bangsberg, D.1
Kroetz, D.2
Deeks, S.3
-
36
-
-
34250733532
-
Risk of selecting resistance mutations during treatment interruption
-
Martinez-Picado J, Wai Yan Tam L. Risk of selecting resistance mutations during treatment interruption. Curr Opin HIV AIDS. 2007;2:6-13.
-
(2007)
Curr Opin HIV AIDS
, vol.2
, pp. 6-13
-
-
Martinez-Picado, J.1
Wai Yan Tam, L.2
-
37
-
-
67651085608
-
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance
-
Gardner E, Burman W, Steiner J, Anderson P, Bangsberg D. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS. 2009;23:1035-46.
-
(2009)
AIDS
, vol.23
, pp. 1035-1046
-
-
Gardner, E.1
Burman, W.2
Steiner, J.3
Anderson, P.4
Bangsberg, D.5
-
38
-
-
0141518673
-
Intrapartum and neonatal singledose nevirapine compared with zidovudine for prevention of mother-tochild transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
-
Jackson J, Musoke P, Fleming T, et al. Intrapartum and neonatal singledose nevirapine compared with zidovudine for prevention of mother-tochild transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859-68.
-
(2003)
Lancet
, vol.362
, pp. 859-868
-
-
Jackson, J.1
Musoke, P.2
Fleming, T.3
-
39
-
-
40049106667
-
Prevention of mother-to-child transmission, drug resistance, and implications for response to therapy
-
Lockman S. Prevention of mother-to-child transmission, drug resistance, and implications for response to therapy. Curr Opin HIV AIDS. 2008;3:166-72.
-
(2008)
Curr Opin HIV AIDS
, vol.3
, pp. 166-172
-
-
Lockman, S.1
-
40
-
-
77957945728
-
Antiretroviral therapies in women after single-dose nevirapine exposure
-
Lockman S, Hughes M, McIntyre J, et al. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med. 2010;363:1499-509.
-
(2010)
N Engl J Med
, vol.363
, pp. 1499-1509
-
-
Lockman, S.1
Hughes, M.2
McIntyre, J.3
-
42
-
-
72249123176
-
Intracellular pharmacokinetics of antiretroviral drugs in HIV-infected patients, and their correlation with drug action
-
Bazzoli C, Jullien V, Le Tiec C, Rey E, Mentre F, Taburet A. Intracellular pharmacokinetics of antiretroviral drugs in HIV-infected patients, and their correlation with drug action. Clin Pharmacokinet. 2010;49:17-45.
-
(2010)
Clin Pharmacokinet
, vol.49
, pp. 17-45
-
-
Bazzoli, C.1
Jullien, V.2
Le Tiec, C.3
Rey, E.4
Mentre, F.5
Taburet, A.6
-
43
-
-
34547798122
-
Stopping antiretroviral therapy
-
Taylor S, Boffito M, Khoo S, Smit E, Back D. Stopping antiretroviral therapy. AIDS. 2007;21:1673-82.
-
(2007)
AIDS
, vol.21
, pp. 1673-1682
-
-
Taylor, S.1
Boffito, M.2
Khoo, S.3
Smit, E.4
Back, D.5
-
44
-
-
84883098104
-
-
Hansen K, Parthasarathi G, ed.: Orient Blackswan
-
Text Book Of Clinical Pharmacy. Hansen K, Parthasarathi G, ed.: Orient Blackswan; 2004.
-
(2004)
Text Book of Clinical Pharmacy
-
-
-
46
-
-
70049100021
-
HIV-1 resistance to first- and secondgeneration non-nucleoside reverse transcriptase inhibitors
-
Ghosn J, Chaix M, Delaugerre C. HIV-1 resistance to first- and secondgeneration non-nucleoside reverse transcriptase inhibitors. AIDS Rev. 2009;11:165-73.
-
(2009)
AIDS Rev
, vol.11
, pp. 165-173
-
-
Ghosn, J.1
Chaix, M.2
Delaugerre, C.3
-
47
-
-
67449097569
-
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: A systematic review and metaanalysis
-
Gupta R, Hill A, Sawyer A, et al. Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and metaanalysis. Lancet Infect Dis. 2009;9:409-17.
-
(2009)
Lancet Infect Dis
, vol.9
, pp. 409-417
-
-
Gupta, R.1
Hill, A.2
Sawyer, A.3
-
48
-
-
79952414942
-
Global trends in molecular epidemiology of HIV-1 during 2000-2007
-
Hemelaar J, Gouws E, Ghys P, Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS. 2011;25:679-89.
-
(2011)
AIDS
, vol.25
, pp. 679-689
-
-
Hemelaar, J.1
Gouws, E.2
Ghys, P.3
Osmanov, S.4
-
49
-
-
1042287077
-
Drug resistance in non-subtype B HIV-1
-
Kantor R, Katzenstein D. Drug resistance in non-subtype B HIV-1. J Clin Virol. 2004;29:152-9.
-
(2004)
J Clin Virol
, vol.29
, pp. 152-159
-
-
Kantor, R.1
Katzenstein, D.2
-
50
-
-
19344373478
-
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration
-
Kantor R, Katzenstein D, Efron B, et al. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med. 2005;2:e112.
-
(2005)
PLoS Med
, vol.2
-
-
Kantor, R.1
Katzenstein, D.2
Efron, B.3
-
51
-
-
33750519867
-
Impact of HIV-1 pol diversity on drug resistance and its clinical implications
-
Kantor R. Impact of HIV-1 pol diversity on drug resistance and its clinical implications. Curr Opin Infect Dis. 2006;19:594-606.
-
(2006)
Curr Opin Infect Dis
, vol.19
, pp. 594-606
-
-
Kantor, R.1
-
52
-
-
0038298453
-
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution
-
Kantor R, Katzenstein D. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev. 2003;5:25-35.
-
(2003)
AIDS Rev
, vol.5
, pp. 25-35
-
-
Kantor, R.1
Katzenstein, D.2
-
53
-
-
24144438597
-
Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after singledose nevirapine: HIVNET 012
-
Eshleman S, Guay L, Wang J, et al. Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after singledose nevirapine: HIVNET 012. J Acquir Immune Defic Syndr. 2005;40:24-9.
-
(2005)
J Acquir Immune Defic Syndr
, vol.40
, pp. 24-29
-
-
Eshleman, S.1
Guay, L.2
Wang, J.3
-
54
-
-
80053062468
-
The search for a cure for persistent HIV reservoirs
-
Lafeuillade A, Stevenson M. The search for a cure for persistent HIV reservoirs. AIDS Rev. 2011;13:63-6.
-
(2011)
AIDS Rev
, vol.13
, pp. 63-66
-
-
Lafeuillade, A.1
Stevenson, M.2
-
55
-
-
77957063611
-
Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection
-
Turriziani O, Andreoni M, Antonelli G. Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection. Clin Microbiol Infect. 2010;16:1518-24.
-
(2010)
Clin Microbiol Infect
, vol.16
, pp. 1518-1524
-
-
Turriziani, O.1
Andreoni, M.2
Antonelli, G.3
-
56
-
-
17444367748
-
The latent HIV-1 reservoir in patients undergoing HAART: An archive of pre-HAART drug resistance
-
Noe A, Plum J, Verhofstede C. The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance. J Antimicrob Chemother. 2005;55:410-2.
-
(2005)
J Antimicrob Chemother
, vol.55
, pp. 410-412
-
-
Noe, A.1
Plum, J.2
Verhofstede, C.3
-
58
-
-
52749083531
-
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
-
Gazzard B, Anderson J, Babiker A, et al. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008;9:563-608.
-
(2008)
HIV Med
, vol.9
, pp. 563-608
-
-
Gazzard, B.1
Anderson, J.2
Babiker, A.3
-
60
-
-
0032562117
-
Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group
-
Rachlis A, Zarowny D. Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group. CMAJ. 1998;158:496-505.
-
(1998)
CMAJ
, vol.158
, pp. 496-505
-
-
Rachlis, A.1
Zarowny, D.2
-
61
-
-
33751515147
-
CD4+ count-guided interruption of antiretroviral treatment
-
El-Sadr W, Lundgren J, Neaton J, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-96.
-
(2006)
N Engl J Med
, vol.355
, pp. 2283-2296
-
-
El-Sadr, W.1
Lundgren, J.2
Neaton, J.3
-
62
-
-
67649666969
-
CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART
-
Maggiolo F, Airoldi M, Callegaro A, et al. CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART. AIDS. 2009;23:799-807.
-
(2009)
AIDS
, vol.23
, pp. 799-807
-
-
Maggiolo, F.1
Airoldi, M.2
Callegaro, A.3
-
63
-
-
33745003258
-
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): A randomised trial
-
Danel C, Moh R, Minga A, et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. Lancet. 2006;367:1981-9.
-
(2006)
Lancet
, vol.367
, pp. 1981-1989
-
-
Danel, C.1
Moh, R.2
Minga, A.3
-
64
-
-
34147185711
-
Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN)
-
Pogany K, van Valkengoed I, Prins J, et al. Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN). J Acquir Immune Defic Syndr. 2007;44:395-400.
-
(2007)
J Acquir Immune Defic Syndr
, vol.44
, pp. 395-400
-
-
Pogany, K.1
Van Valkengoed, I.2
Prins, J.3
-
65
-
-
33845921356
-
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients
-
Ruiz L, Paredes R, Gomez G, et al. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients. AIDS. 2007;21:169-78.
-
(2007)
AIDS
, vol.21
, pp. 169-178
-
-
Ruiz, L.1
Paredes, R.2
Gomez, G.3
-
66
-
-
57649228971
-
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption
-
Leon A, Martinez E, Milinkovic A, et al. Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption. J Antimicrob Chemother. 2009;63:184-8.
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 184-188
-
-
Leon, A.1
Martinez, E.2
Milinkovic, A.3
-
67
-
-
37549062973
-
Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl
-
DART Trial Team
-
DART Trial Team. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl. AIDS. 2008;22:237-47.
-
(2008)
AIDS
, vol.22
, pp. 237-247
-
-
-
68
-
-
1642339461
-
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: A controlled, prospective trial
-
Maggiolo F, Ripamonti D, Gregis G, Quinzan G, Callegaro A, Suter F. Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial. AIDS. 2004;18:439-46.
-
(2004)
AIDS
, vol.18
, pp. 439-446
-
-
Maggiolo, F.1
Ripamonti, D.2
Gregis, G.3
Quinzan, G.4
Callegaro, A.5
Suter, F.6
-
69
-
-
33847794452
-
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death
-
Holkmann Olsen C, Mocroft A, Kirk O, et al. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med. 2007;8:96-104.
-
(2007)
HIV Med
, vol.8
, pp. 96-104
-
-
Holkmann Olsen, C.1
Mocroft, A.2
Kirk, O.3
-
70
-
-
20144370827
-
Interruption of highly active antiretroviral therapy in HIV clinical practice: Results from the Italian Cohort of Antiretroviral-Naive Patients
-
d'arminio Monforte A, Cozzi-Lepri A, Phillips A, et al. Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients. J Acquir Immune Defic Syndr. 2005;38:407-16.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 407-416
-
-
D'Arminio Monforte, A.1
Cozzi-Lepri, A.2
Phillips, A.3
-
71
-
-
79951517916
-
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death
-
Kaufmann G, Elzi L, Weber R, et al. Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS. 2011;25:441-51.
-
(2011)
AIDS
, vol.25
, pp. 441-451
-
-
Kaufmann, G.1
Elzi, L.2
Weber, R.3
-
72
-
-
67449146275
-
Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up
-
Knobel H, Urbina O, Gonzalez A, et al. Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up. HIV Med. 2009;10:364-9.
-
(2009)
HIV Med
, vol.10
, pp. 364-369
-
-
Knobel, H.1
Urbina, O.2
Gonzalez, A.3
-
73
-
-
20044394359
-
Long-term consequences of treatment interruptions in chronically HIV-1-infected patients
-
Wolf E, Hoffmann C, Procaccianti M, et al. Long-term consequences of treatment interruptions in chronically HIV-1-infected patients. Eur J Med Res. 2005;10:56-62.
-
(2005)
Eur J Med Res
, vol.10
, pp. 56-62
-
-
Wolf, E.1
Hoffmann, C.2
Procaccianti, M.3
|